Return On Equity	(Mar 31 2022) 2022	(Mar 31 2021) 2021	(Mar 31 2020) 2020	(Mar 31 2019) 2019	(Mar 31 2018) 2018
Y / Y Equity Change	15.09 %	21.99 %	7.67 %	2.59 %	85.89 %
Y / Y Net Income Change	1.89 %	16.69 %	53.24 %	14.76 %	106.18 %
Return On Equity	10.27 %	11.6 %	12.13 %	8.52 %	7.62 %

CO all Ratios >> Back to CO Management Effectiveness >> See Quarterly CO Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Mar 31 2022) ROE detoriated to 10.27 %, despite net income growth.

Financial Statements
Global Cord Blood's Equity	$ 770 Millions	Annual CO's Balance sheet
Global Cord Blood's Annual Income	$ 79 Millions	Annual CO's Income Statement
Where are CO's Income coming from?		Visit CO's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.